Genetic Signatures Limited (ASX:GSS) Might Not Be As Mispriced As It Looks After Plunging 30%
Apr 11
Have your own idea? Try our Stock Screener
Australian (ASX) Healthcare Sector Analysis
UpdatedApr 14, 2025
DataAggregated Company Financials
Companies133
- 7D-3.7%
- 3M-15.9%
- 1Y-9.8%
- YTD-13.4%
Over the last 7 days, the Healthcare industry has dropped 3.7%, driven by a pullback from CSL of 8.0%. In contrast, Pro Medicus has gained 6.8%. However, the industry is down 9.8% over the past year. As for the next few years, earnings are expected to grow by 18% per annum.
Sector Valuation and Performance
Has the Australian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 15 Apr 2025 | AU$237.7b | AU$71.1b | AU$5.0b | 25.8x | 47.9x | 3.3x |
| Thu, 13 Mar 2025 | AU$250.1b | AU$71.2b | AU$4.9b | 27.7x | 50.7x | 3.5x |
| Sat, 08 Feb 2025 | AU$248.1b | AU$65.2b | AU$3.3b | 26.5x | 74.2x | 3.8x |
| Mon, 06 Jan 2025 | AU$247.0b | AU$68.9b | AU$3.4b | 25.9x | 73.3x | 3.6x |
| Wed, 04 Dec 2024 | AU$250.4b | AU$68.0b | AU$3.2b | 27x | 78x | 3.7x |
| Fri, 01 Nov 2024 | AU$239.9b | AU$67.7b | AU$3.2b | 25.3x | 75.8x | 3.5x |
| Sun, 29 Sep 2024 | AU$236.6b | AU$66.5b | AU$3.0b | 25.8x | 79.3x | 3.6x |
| Tue, 27 Aug 2024 | AU$245.2b | AU$65.3b | AU$3.2b | 36.7x | 77.3x | 3.8x |
| Thu, 25 Jul 2024 | AU$246.1b | AU$63.0b | AU$2.7b | 32.1x | 92.7x | 3.9x |
| Sat, 22 Jun 2024 | AU$236.1b | AU$62.8b | AU$2.6b | 33.5x | 90x | 3.8x |
| Mon, 20 May 2024 | AU$225.3b | AU$60.9b | AU$2.6b | 26.8x | 87.4x | 3.7x |
| Wed, 17 Apr 2024 | AU$221.6b | AU$62.0b | AU$2.7b | 25.6x | 81.2x | 3.6x |
| Fri, 15 Mar 2024 | AU$223.2b | AU$61.4b | AU$2.6b | 25.6x | 85.6x | 3.6x |
| Sun, 11 Feb 2024 | AU$235.0b | AU$59.2b | AU$3.0b | 26.1x | 77.2x | 4x |
| Tue, 09 Jan 2024 | AU$223.3b | AU$60.1b | AU$2.8b | 24.5x | 79.8x | 3.7x |
| Thu, 07 Dec 2023 | AU$210.4b | AU$60.5b | AU$2.9b | 24.8x | 73.2x | 3.5x |
| Sat, 04 Nov 2023 | AU$193.6b | AU$60.9b | AU$2.9b | 24.4x | 65.8x | 3.2x |
| Mon, 02 Oct 2023 | AU$200.1b | AU$61.1b | AU$2.9b | 24.9x | 68.9x | 3.3x |
| Wed, 30 Aug 2023 | AU$210.2b | AU$61.5b | AU$2.9b | 29x | 71.3x | 3.4x |
| Fri, 28 Jul 2023 | AU$213.7b | AU$57.4b | AU$2.8b | 27.5x | 75.3x | 3.7x |
| Sun, 25 Jun 2023 | AU$217.4b | AU$57.7b | AU$2.9b | 25.5x | 75.3x | 3.8x |
| Tue, 23 May 2023 | AU$231.6b | AU$57.8b | AU$2.9b | 27.5x | 80.1x | 4x |
| Thu, 20 Apr 2023 | AU$230.4b | AU$57.1b | AU$2.9b | 27.5x | 80.4x | 4x |
| Sat, 18 Mar 2023 | AU$221.0b | AU$57.0b | AU$2.9b | 24.9x | 77.5x | 3.9x |
| Mon, 13 Feb 2023 | AU$226.1b | AU$55.3b | AU$4.0b | 24.9x | 57.2x | 4.1x |
| Wed, 11 Jan 2023 | AU$213.0b | AU$55.3b | AU$4.0b | 24.8x | 53.2x | 3.8x |
| Fri, 09 Dec 2022 | AU$224.3b | AU$55.8b | AU$4.1b | 24.9x | 54.9x | 4x |
| Sun, 06 Nov 2022 | AU$210.7b | AU$56.8b | AU$4.3b | 25.3x | 49.3x | 3.7x |
| Tue, 04 Oct 2022 | AU$210.5b | AU$56.4b | AU$4.2b | 28x | 50x | 3.7x |
| Thu, 01 Sep 2022 | AU$224.5b | AU$55.0b | AU$4.1b | 27.7x | 54.5x | 4.1x |
| Sat, 30 Jul 2022 | AU$221.9b | AU$53.8b | AU$4.8b | 24x | 46.2x | 4.1x |
| Mon, 27 Jun 2022 | AU$205.7b | AU$53.9b | AU$4.8b | 24x | 42.6x | 3.8x |
| Wed, 25 May 2022 | AU$215.1b | AU$53.5b | AU$4.7b | 25x | 45.3x | 4x |
| Fri, 22 Apr 2022 | AU$219.0b | AU$56.8b | AU$4.7b | 27.2x | 47x | 3.9x |
Price to Earnings Ratio
47x
Current Industry PE
- Investors are pessimistic on the Australian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 47.9x which is lower than its 3-year average PE of 68.8x.
- The 3-year average PS ratio of 3.7x is higher than the industry's current PS ratio of 3.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 2.0% per year over the last three years.
- Revenues for these companies have grown 7.8% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Australian Healthcare sector?
| AU Market | 0.085% | |
| Healthcare | -3.67% | |
| Healthtech | 6.24% | |
| Healthcare Services | -0.13% | |
| Life Sciences | -2.53% | |
| Medical Equipment | -2.98% | |
| Pharma | -4.99% | |
| Biotech | -6.85% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 199x.
- Analysts are expecting annual earnings growth of 15.4%, which is lower than the prior year's growth of 19.6% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 82% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Biotech industry is expected to see its earnings grow by 15% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PME Pro Medicus | AU$212.92 | 20.4% +AU$3.8b | 100.2% | PE226.3x | |
| SIG Sigma Healthcare | AU$3.00 | 6.4% +AU$2.1b | n/a | PE64x | |
| TLX Telix Pharmaceuticals | AU$26.36 | 13.9% +AU$1.1b | 104.2% | PE178.3x | |
| COH Cochlear | AU$261.00 | 3.0% +AU$501.6m | -18.0% | PE46.1x | |
| SHL Sonic Healthcare | AU$25.21 | 2.4% +AU$278.5m | -5.7% | PE22.2x |
